Job Search, Employment & Careers Site. Find Jobs. Build a Better Career.
English | Français
 
 
 
News
22.08.2016
 
A novel gene-therapy solution for Parkinson’s patients

Parkinson’s patients who take the drug levodopa, or L-Dopa, are inevitably disappointed. At first, during a “honeymoon” period, their symptoms (which include tremors and balance problems) are brought under control. But over time the drug becomes less effective. They may also need ultrahigh doses, and some start spending hours a day in a state of near-frozen paralysis.


A biotech company called Voyager Therapeutics now thinks it can extend the effects of L-Dopa by using a surprising approach: gene therapy. The company, based in Cambridge, Massachusetts, is testing the idea in Parkinson’s patients who’ve agreed to undergo brain surgery and an injection of new DNA….


Source: MIT Tech Review


Plus

Republic of Innovation
 
22.08.2016
 
Re-educating the immune system
After an organ transplant, a patient must take powerful drugs to suppress rejection of the new body part. The EU-funded THE ONE STUDY project is testing whether some of the body's own immune cells can improve organ acceptance. Initial clinical trials are underway.
EUROPA - Research Information Centre
 
21.08.2016
 
«Blutende» Rosskastanien: Neuer Erreger in der Schweiz gefunden
Seit 2015 befällt ein asiatisches Bakterium Rosskastanien in der Schweiz und verursacht einen schwarzbraunen, blutähnlichen Ausfluss am Stamm. Experten der Eidg. Forschungsanstalt WSL empfehlen Vorsichtsmassnahmen.
Eidg. Forschungsanstalt für Wald, Schnee und Landschaft WSL
 
19.08.2016
 
A big step forward in the quest for a better painkiller

Scientists have designed a promising new painkiller that appears to separate the powerful pain dulling effects of synthetic opioids from side effects that include physical dependence, constipation, and potentially fatal respiratory depression.


To find the new drug–named PZM21 and detailed in a paper published today in Nature–a research team at UCSF’s School of Pharmacy simulated some four trillion different chemical interactions between the brain’s “morphine receptors,” and a virtual library of close to 4 million commercially available drug compounds. Choosing the best candidates, they then worked in collaboration with researchers from three other institutions to develop a compound that functioned in the way they hoped, after testing it in mice.


Source: MIT Tech Review


Plus

Republic of Innovation
 
19.08.2016
 
Un patch connecté pour se protéger des rayons UV

La crème solaire, on en met, on se baigne et passé quelques heures, on ne sait plus vraiment si on est toujours protégé. Pour faire le point en un clic, à l’aide de son smartphone, une entreprise française de produits dermatologiques a trouvé la solution. Un patch résistant à l’eau réalisé à l’image des faux tatouages d’été, à la mode actuellement, doté d’un capteur qui mesure l’exposition aux UV.


Le «My UV patch», créé par La Roche-Posay donne, via une application smartphone, des conseils personnalisés en fonction des rayons captés et du type de peau sur laquelle il est collé. Il est doté de colorants photosensibles qui changent de couleur en fonction de la dose d’UV à laquelle il est exposé. Ces couleurs sont ensuite analysées en fonction des données personnelles de l’utilisateur via un algorithme pour permettre à l’application de donner des conseils adaptés…


Source: Le Matin


Plus

Republic of Innovation
 
1  2  3  4  5  6  7  8  9  10  ...  
 
Contact Us  |   About Osmmos  |   Privacy Policy  |   Top Training © 2009 Osmmos
Powered by Job Site Pro - Job Board Software and Job Script